STOCK TITAN

Artelo Biosciences, Inc. (ARTL) Net Income by Year

ARTL

Artelo Biosciences, Inc. reported a net loss of $12.9M in fiscal year 2025. This represents a decrease of 31.1% from the prior fiscal year. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters Artelo Biosciences, Inc. has filed alongside them.

FY2025 annual
Net Income -$12.9M
YoY -31.1%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ARTL Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY238-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-K
Net Income-$12.9M-31.1%-$9.8M-5.8%-$9.3M+7.9%-$10.1M-7.2%-$9.4M-102.1%-$4.7M-114.3%-$2.2MN/A-$235KN/A-$15K+0.2%-$15K

ARTL Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'238-KQ3'2310-Q
Net Income-$2.4M+24.7%-$3.0M-24.7%N/A-$3.1M-175.6%-$3.2M-32.4%-$2.4M+4.5%N/A-$1.1M+53.8%-$2.4M-52.2%-$2.5M-14.5%N/A-$2.4M-5.1%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Artelo Biosciences, Inc. financials

Frequently Asked Questions

What was Artelo Biosciences, Inc.'s net income in fiscal year 2025?

Artelo Biosciences, Inc. reported a net loss of $12.9M in fiscal year 2025.

How fast is Artelo Biosciences, Inc.'s net income growing?

Artelo Biosciences, Inc. (ARTL) net income fell by 31.1% year over year, from -$9.8M to -$12.9M in fiscal year 2025.

How has Artelo Biosciences, Inc.'s net income changed over the years?

Across the 12 fiscal years this page covers, Artelo Biosciences, Inc. (ARTL) net income went from -$15K in fiscal year 2014 to -$12.9M in fiscal year 2025.

Artelo Biosciences, Inc. (ARTL) reported -$2.4M in net income in Q2 2026. This represents an increase of 24.7% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Artelo Biosciences, Inc. (ARTL) reported on that line in every period on record.